HIV activist battles drugs and discrimination in Ukraine

Growing up in eastern Ukraine, Svitlana Moroz said she was a typically reckless teenager who believed she’d live forever. She shared needles with friends to inject opium, had unprotected sex with a guy her own age, and five months after hooking up with him, learned she ...

February 13, 2017
EATG  News  

Collaboration on novel cellular therapies for long term HIV control

Bioquark Inc. and SC21 Biotech are collaborating on novel cellular therapies for long term HIV control by cost effectively and industrially scaling the production of HIV resistant cells for allogeneic transplant needs. Phialdelphia, PA, February 11, 2017 – Bioquark, Inc., (http://www.bioquark.com) a life sciences company focused ...

February 13, 2017
EATG  News  

Progress toward HIV cure highlighted

New Rochelle, NY, February 9, 2017—A comprehensive collection of articles describing the broad scope and current status of this global effort is published in a special issue of AIDS Research and Human Retroviruses, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The third annual ...

February 13, 2017
EATG  News  

WHO calls for list of essential diagnostics

Last June, a Perspective piece in the New England Journal of Medicine noted the critical place that the World Health Organization’s list of Essential Medicines had assumed in global health policy and responses — donors, governments and insurers were all more likely to invest in ...

February 13, 2017
EATG  News